New Drugs and Expanded Indications

MSHO will periodically provide information about newly approved therapies for cancer patients by the FDA and/or pharmaceutical updates to current therapies. This provides oncologists, hematologists, and professionals in oncology-related fields about recent approvals in a timely manner. Included will be a link to the product label, which will provide the relevant clinical information on the indication, contraindications, dosing, and safety. In providing this information, MSHO does not endorse any product or therapy and does not take any position on the safety or efficacy of the product or therapy described.

To view current and resolved drug shortages and discontinuations reported to FDA click here.